: Implementing Standardized Developmental Screening in the - - PowerPoint PPT Presentation

implementing standardized developmental screening in the
SMART_READER_LITE
LIVE PREVIEW

: Implementing Standardized Developmental Screening in the - - PowerPoint PPT Presentation

: Implementing Standardized Developmental Screening in the Patient & Family-Centered Medical Home September 10, 2013 Welcome! Type questions into the Questions Pane Patient-Centered Primary Care Institute History and Development


slide-1
SLIDE 1

Implementing Standardized Developmental Screening in the Patient & Family-Centered Medical Home

September 10, 2013 :

slide-2
SLIDE 2

Welcome! Type questions into the Questions Pane

slide-3
SLIDE 3

Patient-Centered Primary Care Institute History and Development

  • Launched in 2012
  • Public-private partnership
  • Broad array of technical

assistance for practices at all stages of transformation

– Learning Collaboratives – Website (www.pcpci.org) – Webinars & Online Learning

  • Ongoing mechanism to support

practice transformation and quality improvement in Oregon

slide-4
SLIDE 4

Oregon’s PCPCH Model is defined by six core attributes, each with specific standards and measures

  • Access to Care

– “Be there when we need you”

  • Accountability

– “Take responsibility for us to receive the best possible health care”

  • Comprehensive Whole Person Care

– “Provide/help us get the health care and information we need”

  • Continuity

– “Be our partner over time in caring for us”

  • Coordination and Integration

– “Help us navigate the system to get the care we need safely and timely manner”

  • Person and Family Centered Care

– “Recognize we are the most important part of the care team, and we our responsible for our overall health and wellness”

Read more: http://primarycarehome.oregon.gov

PCPCH Model of Care

slide-5
SLIDE 5

Sherri Alderman, MD, MPH, IMH-E, FAAP

START Medical Director & Developmental Behavioral Pediatrician

R.J. Gillespie, MD, FAAP

General Pediatrician, The Children’s Clinic

Rosalia Messina

Parent presenter

Peg King, MPH, MA

START Program Manager

Presenters:

slide-6
SLIDE 6

A Project of:

The Oregon Pediatric Society Oregon Chapter of the American Academy of Pediatrics (AAP)

Sponsored by:

Ford Family Foundation Lora L. and Martin N. Kelley Family Foundation Trust Project LAUNCH Oregon Health Authority

In collaboration with:

ABCDIII; Oregon Dept. of Education; EI/ECSE; 211; Childcare Resource and Referral; County Health Departments; School-Based Health Centers

slide-7
SLIDE 7
  • GIVE an overview of standardized developmental screening

in pediatric practices

  • IMPROVE provider understanding, utilization and

implementation of the Ages and Stages (ASQ) screening tool

  • EDUCATE pediatric providers in proper documentation,

coding, and billing of screenings

  • PROVIDE a family’s perspective on developmental

screening at well child visits

Goals & Objectives

slide-8
SLIDE 8

AGENDA

Part 1: Standardized Developmental Screening As Evidence-Based Practice Part 2: Recommended Developmental Screening Tools & Coding Part 3: Parent Perspective on Screening (Rosalia Messina) Part 4: Clinic Implementation (Dr. RJ Gillespie)

slide-9
SLIDE 9

Did you know? 20% of all visits to the pediatric clinician’s office are developmental or

behavioral in nature

80% of parental concerns are correct and accurate

Children who fall behind in 1st grade have a 1/8 chance of ever catching up High school graduation rates can be accurately predicted by reading level in 3rd grade

slide-10
SLIDE 10

Child Healthcare Providers

THE ONE PLACE NEARLY ALL CHILDREN ARE SEEN

90%

47%

Seen by primary care provider (0-5) Seen by nursery and preschool (3 & 4)

slide-11
SLIDE 11

Myths and Barriers to Screening

  • “Not enough time”
  • “I know it when I see it”
  • Reliance on homemade tools/check lists
  • The “wait and see” approach
  • Lack of knowledge on standardized tools & billing
  • Literacy issues (health & academic)
  • Lack of knowledge of referral resources
slide-12
SLIDE 12

The Facts About Developmental Screening

Developmental screening = higher family- centered care ratings and higher satisfaction with WCC.

Routine developmental screening using a standardized tool complies with:

  • Oregon’s Patient-Centered Primary Care Home (PCPCH)
  • Coordinated Care Organization’s (CCO) performance metrics
  • American Academy of Pediatrics (AAP) Policy Statement – Screen at all 9, 18

and 30 (or 24) month well child visits

  • Bright Futures guidelines
slide-13
SLIDE 13

Implementing ASQ in Practice

10 20 30 40 50 60 70 12-months 24-months

control year screening year

At 12 months, referrals 8X higher At 24 months, referrals 2.5X higher REFERRAL RATES DRAMATICALLY INCREASE

slide-14
SLIDE 14

EARLY REFERRAL & INTERVENTION SERVICES WORK

 EI programs can help improve IQ, motor, language and academic achievement.  Average total expenditure per child in EI is $15,740.  50% of children who receive EI services no longer need services by 3 years of age.  Estimated cost of failing to provide intervention for children living in poverty is as high as $100,000 per child.

slide-15
SLIDE 15

What’s the difference?

Surveillance vs. Screening vs. Diagnosis

slide-16
SLIDE 16

SURVEILLANCE

Flexible Continuous Identifies risk and resiliency Professional’s skilled observations of children during child health care in consultation with other professionals and caregivers Surveillance is NOT screening

slide-17
SLIDE 17

Surveillance

5 COMPONENTS

  • 1. Parents’ concerns
  • 2. Developmental history
  • 3. Risk and protective factors
  • 4. Observations of the child
  • 5. Documenting process and findings
slide-18
SLIDE 18

Screening

  • Set point in time
  • Objective
  • Standardized tool
  • Differentiates children that

are "probably ok" vs. "needing additional investigation”

slide-19
SLIDE 19

WHAT IS DIAGNOSIS & EVALUATION?

  • 1. Diagnosis is the next step when screening identifies child as

“needing additional investigation”

  • 2. Diagnosis is done by a professional with expertise in

developmental evaluation

  • 3. Aimed at identifying specific developmental disorders affecting

the child, “diagnostic”

  • 4. Done in conjunction with a medical diagnostic evaluation

Every child diagnosed with a developmental delay should receive a medical evaluation to assess for possible co-existing medical conditions.

slide-20
SLIDE 20

Benefits of Screening

  • Better Patient Care
  • Improved Patient/Family Satisfaction
  • Earlier Identification & Referral
  • Improved Child/Family Outcomes
  • Reimbursable
  • Cost Effective
  • CCO and PCPCH metric

EARLY INTERVENTION IS PREVENTION

slide-21
SLIDE 21

Advantages of Using Parent-Completed Screening Tools

 Can be used to focus the visit on parental concerns Enhances teachable moments Helps avoid “oh, by the way” questions Parents/caregivers can provide rich information about child across settings Improves patient flow Improves patient/family satisfaction

slide-22
SLIDE 22

Sensitivity: 76-90% Specificity: 76-91% Cost: $225, unlimited copying Ages: 2 months to 5 ½ years (adjust for prematurity) Format: parent questionnaire, 5 domains Languages: English & Spanish Reading Level: 4th to 6th grade level Time required to score: 3 minutes Interpretation: white, gray, black Website for info and to order: www.agesandstages.com

Ages & Stages Questionnaire

slide-23
SLIDE 23

Preparing Parents & Caregivers

  • Explain tool and

purpose to parents

  • Normalize

developmental screening

  • Assess ability to complete tool properly
slide-24
SLIDE 24

Ages & Stages™ Sample Item

9 Month Questionnaire - Scoring

Yes Sometimes Not Yet    10 Yes Sometimes Not Yet    5

 

  • 1. While your baby is on

her back, does she put her foot in her mouth?

  • 2. Does your baby drink

water, juice, or formula from a cup while you hold it?

slide-25
SLIDE 25

ASQ™ Scoring

  • Be sure each item has been answered.
  • Corrections can be made if two or less items are left blank.
  • The scoring grid below shows the cutoff score for each domain,

indicated by the dark bar.

  • Any score touching or in the dark bar indicates further evaluation is

needed.

  • Gray area corresponds to 1.5 SD below mean, black area corresponds

to 2.0 SD below mean

slide-26
SLIDE 26

Common Referral Form: HIPAA & FERPA Consent

The goal of the dual consent is to enhance communication by allowing child health providers and EI/ECSE to release important information to one another, better ensuring children and families are getting the care they need.

slide-27
SLIDE 27

Coding and Documentation of Developmental Screening

  • Coding 96110 is multi-purpose: tracking screening rates, CCO

and PCPCH metrics reporting, +/- billing

  • To submit code for reimbursement or not? Requires careful

consideration of pros and cons by each clinic (See OPIP resource)

  • Typically reported when performed during preventive service

visit

  • Scoring can be done by physician, nurse, or MA; Discussion of

results must be done by medical provider

  • Document name of tool administered, total score,

interpretation (pass / fail), and “discussed with family”

slide-28
SLIDE 28

Coding 96110

  • Decision to bill or not and amount must be applied to all

insurance types. To not bill uniformly is an unacceptable billing

  • practice. (See OPIP coding and billing resource)
  • 96110: “Developmental screening with interpretation and

report, per standardized instrument form” (CPT 2013)

  • may be billed multiple times during a visit if more than one

tool is used

  • Attach -25 modifier to well child code
  • Attach -59 modifier to 96110 code only if multiple codes

billed

  • If claim is rejected, send AAP letter (see resources) to Medical

Director of insurance plan along with copy of AAP developmental screening guidelines

slide-29
SLIDE 29

Next Steps

 Encourage communication and follow-up on referrals. Use the Common Referral Form and establish a feedback loop with referral agencies. Schedule a START clinic-based training for a more detailed training on workflow, quality improvement strategies, and how to connect with your local community resources and agencies

slide-30
SLIDE 30

Continuous PDSA Cycles

ACT ST UDY PL AN DO ACT ST UDY PL AN DO ACT ST UDY PL AN DO

Hunches, theories, ideas Changes that result in improvement

slide-31
SLIDE 31

What does a parent have to say?

A conversation with Rosalia Messina

  • What was your experience with your child's

developmental screening at the doctor's office?

  • What feedback do you have for doctors?
  • What would you like to say to other parents

about the developmental screening process?

slide-32
SLIDE 32

Implementation in the clinical setting

A conversation with R.J. Gillespie, MD

1. Clinic history 2. Change 3. Barriers 4. Implementing screening and START’s role in the process 5. Challenges in monitoring 6. Screening today 7. The future

slide-33
SLIDE 33

Additional Trainings

  • Autism
  • Post partum depression
  • Social emotional development
  • Adolescent depression
  • and more
  • START provides CME and MOC for medical

providers’ participation in trainings

slide-34
SLIDE 34

For more information or to schedule a training, please visit:

www.oraap.org/start

For more information: Peg King, 503.334.1591 x101 or margaret.king@oraap.org

slide-35
SLIDE 35

Questions? Type questions into the Questions Pane

slide-36
SLIDE 36

Resources

  • American Academy of Pediatrics: The Medical Home
  • Referral Form
  • CCO Guidance Document – Developmental Screening for

Young Children

  • OPIP Billing Slides
  • Sample Claim Letter

Available on www.pcpci.org attached to webinar Thank you! Please complete our post-webinar survey!

slide-37
SLIDE 37

References

  • Olson AC. How to establish family professional partnerships. Presented at: International Family Centered Care Conference September 5, 2003;

Boston, MA

  • Facts About Childhood Literacy,” Education Commission of the States, 2001: Last accessed 10/20/11 at

http//www.ecs.org/clearinghouse/29/81/2981.htm.

  • Annie E. Casey Foundation, 2012 Kid’s Count Data Book
  • National Survey of Children's Health. NSCH 2011/12. Data query from the Child and Adolescent Health Measurement Initiative, Data Resource

Center for Child and Adolescent Health website. Retrieved 5/6/13 from www.childhealthdata.org

  • Journal of Developmental/ Behavioral Pediatrics 24:409–417, 2003
  • Halfon, N., Regalado, M., Sareen, H., et al. (2006). Assessing Development in the Pediatric Office. Pediatrics 113(6);1926-1933.
  • VanLandeghem, K., (2002). Reasons and strategies for strengthening childhood development services in the healthcare system.
  • National Academy for State Health Policy: The Commonwealth Fund.
  • Hollie Hix-Small, Kevin Marks, Jane Squires and Robert Nickel, Impact of Implementing Developmental Screening at 12 and 24 Months in a

Pediatric Practice, Pediatrics 2007;120;381

  • Barnett, W. S. (1995). Long-term effects of early childhood programs on cognitive and school outcomes. The Future of Children Long-
  • Term Outcomes of Early Childhood Porgrams 5(3), 25-50.
  • Castro, G. & Mastropieri, M. A. (1986). The efficacy of early intervention programs: A meta-analysis. Exceptional Children, 52, 417-424.
  • Hebbeler, K., Spiker, D., et al. (2007). Early intervention for infants and toddlers with disabilities and their families: Participants, services, and
  • utcomes, NEILS Final Report. Accessed November 3, 2011 at http://www.sri.com/neils/pdfs/NEILS_Final_Report_02_07.pdf
  • Palfrey, J. S., Hauser-Cram, P., Bronson, M. B., Warfield, M. E., Sirin, S., & Chan, E. (2005). The Brookline early education project: A 25-year

follow-up study of a family-centered early health and development intervention. Pediatrics, 116(1), 144-152. Retrieved December 21, 2006, from http://www.pediatrics.org/cgi/content/full/116/1/144

  • White, K.R., (1985). Efficacy of early intervention. Journal of Special Education 19(4), 401-416.
  • SM Dworkin, A Shannon, and P Dworkin. ChildServ Curriculum. Center for Children’s Health and Development, St. Francis Hospital and Medical

Center; 1999; Hartford, CT.

  • AAP Policy - Pediatrics 2006; 118; 405-420